An Exploratory Study of Dietary Management Apps in Adults with Type 2 Diabetes
- Conditions
- Type 2 diabetic
- Registration Number
- JPRN-jRCTs032220491
- Lead Sponsor
- Ishii Hideto
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 8
1) Patients who are using insulin in the diagnosis of type 2 diabetes
2) Patients with HbA1c >=7.0% and <=10.0% at -8 weeks (retrospective data)
3) Body Mass Index (BMI): Patients with BMI of more than 18.5 kg/m2 and less than 35.0 kg/m2
4) Age at the time of obtaining consent: Patients over 20 years of age
5) Gender: Regardless
6) Patients for whom written consent has been obtained to participate in this study by their own free will
1) Patients with type 1 diabetes
2) Patients with steroid diabetes
3) Pregnant patients
4) Patients with diabetic nephropathy Stage 3-5
5) Patients currently diagnosed with cancer and undergoing treatment
6) Patients with hemoglobin less than 11.0 g/dL within 1 year before informed consent
7) Patients who received a blood transfusion within one month
8) Patients who plan to receive blood transfusions during clinical trials
9) Furthermore, patients whose participation in this study is inappropriate by the principal or sub investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of the amount of change in HbA1c from week 8 before the treatment period to week 0 and from week 0 of the treatment period to week 8
- Secondary Outcome Measures
Name Time Method